The "Pharm Exec 50" ranks the world’s largest pharmaceutical companies by global sales of prescription drugs—a key indicator of market change. After last year’s storm of activity, the 50 set a more placid pace, as major players worked on integrating blockbuster mergers and licked their wounds after the latest round of Phase III failures.
